WMore world news on WWN →

GSK shares dive as weaker sales and mounting costs unnerve investors

The Guardian World•
GSK shares dive as weaker sales and mounting costs unnerve investors

British pharma company reports declining profits amid concerns over looming patent loss of its blockbuster HIV drug Shares in GSK slid on Wednesday despite the UK drugmaker reporting…

Read Full Article on The Guardian World

Related stories